PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
August 20, 2025World Journal of Clinical Oncology0 citations

Correction to “Clinicohistopathological implications of phosphoserine 9 glycogen synthase kinase-3β/ β-catenin in urinary bladder cancer patients”

View Full Paper
NMNiharika MauryaRSRinni SinghAGApul Goel

Key Points

  • A correction note clarifies details about phosphoserine 9 glycogen synthase kinase-3β in bladder cancer.
  • The article originally published addresses important clinicohistopathological implications.
  • This correction serves to ensure accuracy and reliability in the understanding of β-catenin in relation to urinary bladder cancer.
  • The implications for urinary bladder cancer patients are significant, highlighting the need for precise information.

Abstract

Correction to “Maurya N, Singh R, Goel A, Singhai A, Singh UP, Agrawal V, Garg M. Clinicohistopathological implications of phosphoserine 9 glycogen synthase kinase-3β/ β-catenin in urinary bladder cancer patients. World J Clin Oncol 2019; 10(4): 166-182 PMID: 31114749 DOI: 10.5306/wjco.v10.i4.166”. In this article, a correction note is to be added.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Maurya et al. (2025) studied this question.

synapsesocial.com/papers/68af4eb4ad7bf08b1ead74b5https://doi.org/10.5306/wjco.v16.i8.107778
Ask AI
Helpful
Bookmark
Share
View Full Paper